LAMEA Motion Sickness Treatment Market Size, Share & Industry Trends Analysis Report By Drug Class (Antihistamines, Anticholinergics and Others), By Route of Administration, By Distribution Channel, By Country and Growth Forecast, 2023

List of Tables

The Latin America, Middle East and Africa Motion Sickness Treatment Market would witness market growth of 5.1% CAGR during the forecast period (2023-2029).

The motion sickness treatment market is expected to be driven by the increasing adoption of prescription drugs for motion sickness in developed economies in the coming years. Thus, based on the aforementioned factors, the market is anticipated to grow during the forecast period.

Techniques that include traditional neurophysiology, pathway mapping, and magnetic resonance imaging (MRI) have contributed to a deeper understanding of the neurological mechanisms related to motion sickness. Nauseogenic IT has become a widely used approach for studying neurophysiology and brain regions associated with this condition. The utilization of nauseogenic vehicles enables the assessment of an individual's postural stability and the identification of neural or sensory-motor mechanisms that contribute to achieving favorable bodily stability.

The critical knowledge of Nauseogenic information technology can aid in the development and improvement of motion sickness drugs, ultimately contributing to the growth of the industry. The growth of the industry is expected to be positively impacted by the advancement in information technology related to nausea and the easy accessibility of over-the-counter drugs. However, adverse reactions linked to medication for motion sickness may impede the progress of the sector throughout the projected timeframe.

Dubai has become a prominent and popular travel destination within a period of 25 years. The city has demonstrated superior performance compared to other tourism businesses in the past. Dubai is renowned for its naturally formed architectural wonders that attract a large number of tourists, including the Burj Khalifa and Burj Al Arab, which are widely regarded as the most popular tourist attractions.

The increase in vacationers to the region has led to a rise in the tourism sector, attracting more tourists to the region, which are likely to suffer from motion sickness and utilize various treatments medication like anticholinergics and antihistamines, thus surging the market growth in the region.

The Brazil market dominated the LAMEA Motion Sickness Treatment Market by Country in 2022; thereby, achieving a market value of $8.3 Million by 2029. The Argentina market is experiencing a CAGR of 5.7% during (2023 - 2029). Additionally, The UAE market would exhibit a CAGR of 4.8% during (2023 - 2029).

Based on Drug Class, the market is segmented into Antihistamines, Anticholinergics and Others. Based on Route of Administration, the market is segmented into Oral and Others. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies and Online Pharmacies. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Viatris, Inc., Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Baxter International, Inc., Novartis AG, Abbott Laboratories, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd., Prestige Consumer Healthcare, Inc., WellSpring Pharmaceutical Corporation (Avista Capital Partners)

Scope of the Study

Market Segments covered in the Report:

By Drug Class

Antihistamines
Anticholinergics
Others

By Route of Administration

Oral
Others

By Distribution Channel

Drug Store & Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

By Country

Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Companies Profiled

Viatris, Inc.
Teva Pharmaceutical Industries Ltd.
Amneal Pharmaceuticals, Inc.
Baxter International, Inc.
Novartis AG
Abbott Laboratories
Sun Pharmaceutical Industries Ltd.
Zydus Lifesciences Ltd.
Prestige Consumer Healthcare, Inc.
WellSpring Pharmaceutical Corporation (Avista Capital Partners)

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 LAMEA Motion Sickness Treatment Market, by Drug Class
- 1.4.2 LAMEA Motion Sickness Treatment Market, by Route of Administration
- 1.4.3 LAMEA Motion Sickness Treatment Market, by Distribution Channel
- 1.4.4 LAMEA Motion Sickness Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. LAMEA Motion Sickness Treatment Market by Drug Class

3.1 LAMEA Antihistamines Market by Country
3.2 LAMEA Anticholinergics Market by Country
3.3 LAMEA Others Market by Country

Chapter 4. LAMEA Motion Sickness Treatment Market by Route of Administration

4.1 LAMEA Oral Market by Country
4.2 LAMEA Others Market by Country

Chapter 5. LAMEA Motion Sickness Treatment Market by Distribution Channel

5.1 LAMEA Drug Store & Retail Pharmacies Market by Country
5.2 LAMEA Hospital Pharmacies Market by Country
5.3 LAMEA Online Pharmacies Market by Country

Chapter 6. LAMEA Motion Sickness Treatment Market by Country

6.1 Brazil Motion Sickness Treatment Market
- 6.1.1 Brazil Motion Sickness Treatment Market by Drug Class
- 6.1.2 Brazil Motion Sickness Treatment Market by Route of Administration
- 6.1.3 Brazil Motion Sickness Treatment Market by Distribution Channel
6.2 Argentina Motion Sickness Treatment Market
- 6.2.1 Argentina Motion Sickness Treatment Market by Drug Class
- 6.2.2 Argentina Motion Sickness Treatment Market by Route of Administration
- 6.2.3 Argentina Motion Sickness Treatment Market by Distribution Channel
6.3 UAE Motion Sickness Treatment Market
- 6.3.1 UAE Motion Sickness Treatment Market by Drug Class
- 6.3.2 UAE Motion Sickness Treatment Market by Route of Administration
- 6.3.3 UAE Motion Sickness Treatment Market by Distribution Channel
6.4 Saudi Arabia Motion Sickness Treatment Market
- 6.4.1 Saudi Arabia Motion Sickness Treatment Market by Drug Class
- 6.4.2 Saudi Arabia Motion Sickness Treatment Market by Route of Administration
- 6.4.3 Saudi Arabia Motion Sickness Treatment Market by Distribution Channel
6.5 South Africa Motion Sickness Treatment Market
- 6.5.1 South Africa Motion Sickness Treatment Market by Drug Class
- 6.5.2 South Africa Motion Sickness Treatment Market by Route of Administration
- 6.5.3 South Africa Motion Sickness Treatment Market by Distribution Channel
6.6 Nigeria Motion Sickness Treatment Market
- 6.6.1 Nigeria Motion Sickness Treatment Market by Drug Class
- 6.6.2 Nigeria Motion Sickness Treatment Market by Route of Administration
- 6.6.3 Nigeria Motion Sickness Treatment Market by Distribution Channel
6.7 Rest of LAMEA Motion Sickness Treatment Market
- 6.7.1 Rest of LAMEA Motion Sickness Treatment Market by Drug Class
- 6.7.2 Rest of LAMEA Motion Sickness Treatment Market by Route of Administration
- 6.7.3 Rest of LAMEA Motion Sickness Treatment Market by Distribution Channel

Chapter 7. Company Profiles

7.1 Viatris, Inc.
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental Analysis
- 7.1.4 Research & Development Expense
7.2 Teva Pharmaceutical Industries Ltd.
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Regional Analysis
- 7.2.4 Research & Development Expenses
7.3 Amneal Pharmaceuticals, Inc.
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Segmental Analysis
- 7.3.4 Research & Development Expenses
7.4 Baxter International, Inc.
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental Analysis
- 7.4.4 Research & Development Expense
7.5 Novartis AG
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental and Regional Analysis
- 7.5.4 Research & Development Expense
7.6 Abbott Laboratories
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental and Regional Analysis
- 7.6.4 Research & Development Expense
- 7.6.5 SWOT Analysis
7.7 Sun Pharmaceutical Industries Ltd.
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Regional Analysis
- 7.7.4 Research & Development Expenses
7.8 Zydus Lifesciences Ltd.
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Segmental and Regional Analysis
- 7.8.4 Research & Development Expense
- 7.8.5 Recent strategies and developments:
  - 7.8.5.1 Trials and Approvals:
7.9 Prestige Consumer Healthcare, Inc.
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
7.10. WellSpring Pharmaceutical Corporation (Avista Capital Partners)
- 7.10.1 Company Overview

LIST OF TABLES

TABLE 1 LAMEA Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 3 LAMEA Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 4 LAMEA Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 5 LAMEA Antihistamines Market by Country, 2019 - 2022, USD Million
TABLE 6 LAMEA Antihistamines Market by Country, 2023 - 2029, USD Million
TABLE 7 LAMEA Anticholinergics Market by Country, 2019 - 2022, USD Million
TABLE 8 LAMEA Anticholinergics Market by Country, 2023 - 2029, USD Million
TABLE 9 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 10 LAMEA Others Market by Country, 2023 - 2029, USD Million
TABLE 11 LAMEA Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 12 LAMEA Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 13 LAMEA Oral Market by Country, 2019 - 2022, USD Million
TABLE 14 LAMEA Oral Market by Country, 2023 - 2029, USD Million
TABLE 15 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 16 LAMEA Others Market by Country, 2023 - 2029, USD Million
TABLE 17 LAMEA Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 18 LAMEA Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 19 LAMEA Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 20 LAMEA Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 21 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 22 LAMEA Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 23 LAMEA Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 24 LAMEA Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 25 LAMEA Motion Sickness Treatment Market by Country, 2019 - 2022, USD Million
TABLE 26 LAMEA Motion Sickness Treatment Market by Country, 2023 - 2029, USD Million
TABLE 27 Brazil Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 28 Brazil Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 29 Brazil Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 30 Brazil Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 31 Brazil Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 32 Brazil Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 33 Brazil Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 34 Brazil Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 35 Argentina Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 36 Argentina Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 37 Argentina Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 38 Argentina Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 39 Argentina Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 40 Argentina Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 41 Argentina Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 42 Argentina Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 43 UAE Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 44 UAE Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 45 UAE Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 46 UAE Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 47 UAE Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 48 UAE Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 49 UAE Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 UAE Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 51 Saudi Arabia Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 52 Saudi Arabia Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 53 Saudi Arabia Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 54 Saudi Arabia Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 55 Saudi Arabia Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 56 Saudi Arabia Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 57 Saudi Arabia Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 Saudi Arabia Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 59 South Africa Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 60 South Africa Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 61 South Africa Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 62 South Africa Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 63 South Africa Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 64 South Africa Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 65 South Africa Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 66 South Africa Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 67 Nigeria Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 68 Nigeria Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 69 Nigeria Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 70 Nigeria Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 71 Nigeria Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 72 Nigeria Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 73 Nigeria Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 74 Nigeria Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 75 Rest of LAMEA Motion Sickness Treatment Market, 2019 - 2022, USD Million
TABLE 76 Rest of LAMEA Motion Sickness Treatment Market, 2023 - 2029, USD Million
TABLE 77 Rest of LAMEA Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
TABLE 78 Rest of LAMEA Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
TABLE 79 Rest of LAMEA Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
TABLE 80 Rest of LAMEA Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
TABLE 81 Rest of LAMEA Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 82 Rest of LAMEA Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 83 key information - Viatris, Inc.
TABLE 84 Key Information - Teva Pharmaceuticals Industries Ltd.
TABLE 85 Key Information - Amneal Pharmaceuticals, INc.
TABLE 86 Key Information - Baxter International, Inc.
TABLE 87 Key Information - Novartis AG
TABLE 88 Key Information - Abbott Laboratories
TABLE 89 Key Information - Sun Pharmaceutical Industries Ltd.
TABLE 90 Key Information - Zydus Lifesciences Ltd.
TABLE 91 Key Information - Prestige consumer healthcare inc.
TABLE 92 Key Information - WellSpring Pharmaceutical Corporation

List of Figures

FIG 1 Methodology for the research
FIG 2 Swot analysis: Abbott laboratories

LAMEA Motion Sickness Treatment Market Size, Share & Industry Trends Analysis Report By Drug Class (Antihistamines, Anticholinergics and Others), By Route of Administration, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

Description

Table of Contents